Sarepta Therapeutics | Kapitał Własny I Rezerwy



Equity Capital And Reserves Zmiana Data
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Agios Pharmaceuticals USD 1.54B 85.72M 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Amgen USD 5.88B 1.65B 2024-12
Biogen USD 16.72B 357.1M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Daiichi Sankyo JPY 1.62T 1.57B 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
Incyte USD 3.45B 276.41M 2024-12
Insmed USD 285.38M 198.04M 2024-12
Ionis Pharmaceuticals USD 588.35M 74.12M 2024-12
Moderna USD 10.9B 1.03B 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 73B 1.36B 2024-06
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Tectonic Therapeutic USD 150.36M 16.01M 2024-09
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Sarepta Therapeutics Kapitał Własny I Rezerwy - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.